U.S. Maternal Health Devices Market – Industry Trends and Forecast to 2031

U.S. Maternal Health Devices Market Analysis and Size

Rising advancements in medical technology is the major driver for the market growth. Stringent regulatory guidelines by the government bodies restrain the maternal device market. The availability of remote monitoring devices and personalized care is an opportunity for market growth, and the limited access to quality healthcare for maternal health is the major challenge.

Data Bridge Market Research analyzes that the U.S. maternal health devices market is expected to reach USD 3,775.52 million by 2031 from USD 2,618.06 million in 2023 growing with a  CAGR of 4.9% in the forecast period of 2024 to 2031. The obstetric devices segment is projected to propel the market growth due to the rising awareness among expectant mothers.

Market Definition

Maternal health devices refer to a specialized category of medical tools and equipment designed for monitoring, diagnosing, and enhancing the well-being of pregnant women and their unborn babies. These devices encompass various products, including fetal monitoring devices, obstetric tools, birthing beds, delivery chairs, and disposable supplies. The primary objective of maternal health devices is to ensure comprehensive care throughout pregnancy, childbirth, and postpartum, contributing to the safety and health of both the mother and the newborn.

U.S. Maternal Healthcare Devices Market Dynamics

This section deals with understanding the market drivers, opportunities, challenges, and restraints. All of this is discussed in detail below:

Drivers

• Rising Advancements in Medical Technology

Wearable sensors, advanced monitoring systems, and artificial intelligence (AI)-powered analyzers are among the advancements in maternal health equipment contributing to market expansion. Through the provision of comprehensive, real-time insights into pregnancy, maternal health, and fetal well-being, the integration of these technologies is revolutionizing the landscape of maternal care. Pregnant women can take an active role in their care with wearable gadgets equipped with sophisticated sensors that continuously monitor vital signs, fetal heart rate, and uterine contractions. Connectivity in remote monitoring systems and telehealth solutions allows healthcare providers to track pregnancies remotely, make prompt interventions, and provide consultations. This is especially advantageous for women residing in distant or underserved locations.

The wearable technology to examine pregnant mothers in the market has grown quickly due to the rising demand among physicians. The devices, which assist in monitoring and controlling maternal health indicators such as blood pressure, blood glucose, and fetal heart rate at home, range from multifunctional health assessment instruments to fetal monitors. Interest in smart maternal architecture grew as the Internet of Things (IoT) technology became more widely used.

These technologies provide individualized care that caters to each patient's specific need by improving the accuracy and efficiency of maternal health devices.

• Rising Maternal Health Awareness among the Population

Pregnant women's well-being is becoming increasingly dependent on technologies and devices that can monitor, manage, and help enhance their health. This is due to growing awareness among expectant mothers, healthcare professionals, and authorities about the significance of maternal health. A fundamental shift in the perception of maternal health has resulted from this increased knowledge, focusing on the importance of proactive care and ongoing monitoring during pregnancy. Maternal health technologies that provide ease of use, accessibility, and individualized insights into a woman's pregnancy journey are in high demand as expectant mothers look for different methods such as continuous examination, healthy diets, and others to participate actively in their healthcare.

In contrast, healthcare professionals know the necessity for sophisticated diagnostic instruments and all-encompassing monitoring programs to identify possible problems early and enhance maternal outcomes. In accordance with the significant objective of lowering maternal mortality and enhancing general maternal health, there is an increasing demand of devices in the market that provide continuous monitoring of vital signs, fetal health, and post-delivery care.

Opportunity

• Availability Of Remote Monitoring Devices and Personalized Care

The availability of remote monitoring devices and personalized care options is transforming the landscape of maternal health, offering expectant mothers to control and insights into their pregnancy experiences. Pregnant women can participate in real-time monitoring from the comfort of their home due to the growing popularity of wearable technology and telehealth platforms, which promote a sense of empowerment and assurance.

Health-tracking wearables are included in remote monitoring gadgets that are remotely monitoring gadgets becoming essential parts of individualized prenatal treatment. With the use of these devices, expectant mothers can continuously monitor vital signs, movements, and fetal heart rate and other important information. Moreover, to improve the bonding experience between mother and fetus, pregnant mothers can benefit from having access to this real-time data since it gives them additional security and peace of mind. It enables them to swiftly identify possible issues and effectively communicate with their healthcare providers. The intersection of remote monitoring devices and personalized care aligns with the evolving expectations of pregnant mothers who increasingly seek more active involvement in their healthcare journey.

Restraints/Challenges

• Stringent Regulatory Guidelines by the Government Bodies

The strict regulations imposed by governmental authorities pose a major issue in expanding and innovating the maternal health equipment sector in the U.S. Although these rules are meant to guarantee the security, effectiveness, and integrity of medical devices, their complexity, and strictness frequently result in drawn-out approval procedures, higher expenses leading to create a barrier to manufacturers entry into the market. These laws may present difficulties for equipment related to maternal health. Devices that are intended for controlling problems or keeping an eye on high-risk pregnancies are frequently classified as higher-risk, necessitating more stringent clinicaldata and extended approval periods. This may cause a delay in the release of novel medical equipment, restricting the options accessible to healthcare professionals and preventing improvements in maternity care.

The comprehensive fundamentals for obtaining premarket clearances and adhering to quality standards place significant financial strain on producers. Development costs are further increased by the considerable testing, documentation, and compliance processes required to meet these strict regulatory requirements. Therefore, these high expenses might deter funding for the creation of maternal health device R&D and hamper market innovation.

Furthermore, the prolonged regulatory procedures may hamper the prompt delivery of essential maternal health technology, affecting patient access and healthcare results. Delays in introducing innovative devices may limit the ability to improve maternal and fetal health outcomes by impeding the adoption of state-of-the-art options for managing problems. Thus, the stringent regulatory guidelines by the government bodies may restrain the market growth.

• Limited Access to Quality Healthcare for Maternal Health

The limited access to quality healthcare in the U.S., particularly in certain socio-economic and geographic areas, poses challenges for the effective utilization of maternal devices. Maternal health devices are hindered by the shortage of healthcare resources in the U.S., especially in certain socio-economic and geographic areas. The unequal distribution and availability of modern maternal technology can result from disparities in healthcare access, which may limit their general adoption. Pregnant women may have trouble obtaining vital maternal gadgets such as fetal monitors, ultrasounds, or other diagnostic instruments if they live in underprivileged areas with poor access to high-quality healthcare.

 These differences may affect the health outcomes for mothers and fetuses by creating gaps in prenatal and postpartum care. Focused initiatives are needed to enhance the healthcare system, raise public awareness, and support fair access to maternal gadgets to address the issues.

The market for maternal devices is facing significant challenges due to unequal access to quality healthcare, which prevents modern maternal technology from being widely adopted and used fairly. Limited availability in medical conditions increases, and people’s wellness is hampered by limited access to high-quality healthcare. Thus, it is expected to challenge market growth.

Recent Developments                      

• In December 2023, Medotronic announced that it has entered into a definitive agreement to expand its partnership with Cosmo Intelligent Medical Devices, a subsidiary of Cosmo Pharmaceuticals. This AI-driven partnership will further capitalize on the achievements already realized with the GI Genius intelligent endoscopy module, offering continued innovation and scalable healthcare advancements for patients and caregivers globally. Through this exclusive global partnership, Medtronic and Cosmo Pharmaceuticals remain committed to revolutionizing endoscopy by harnessing the power of AI to improve patient outcomes. This strategic alliance reinforces Medtronic's position in AI-integrated healthcare solutions and represents a significant leap in incorporating AI into endoscopic care
• In December 2023, Stryker declared that it has completed a legally binding offer to Menix to purchase the joint replacement business SERF SAS, headquartered in France. Healthcare specialists worldwide acknowledge ERF SAS for its technological advancements, which include creating the first Dual Mobility Cup. With this acquisition, Stryker could provide joint replacements to a larger patient base and enhance its current position in France and throughout Europe in addition to its global joint replacement portfolio
• In July 2023, CANON MEDICAL SYSTEMS CORPORATION introduced the two most recent high-end compact ultrasound systems, the Aplio flex, and Aplio go. The company is aware of the significance of providing the best assistance possible to manage the daily obligations in light of the growing problems healthcare workers face. This has helped the company to expand their product line with innovative technologies

U.S. Maternal Healthcare Device Market Scope

The U.S. maternal healthcare devices market is categorized into six notable segments based on on by product type, modality, stage, type, end user, and distribution channel. The growth amongst these segments will help you analyze major growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Product

• Fetal Monitoring Devices
• Obstetric Devices
• Birthing Beds
• Delivery Chairs
• Disposable Supplies and Consumables
• Others

On the basis of product, the market is segmented into fetal monitoring devices, obstetric devices, birthing beds, delivery chairs, disposable supplies and consumables and others.

Modality

• Handheld
• Portable
• Standalone
• Wearables
• Others

On the basis of modality, the market is segmented into handheld, portable, standalone, wearables, and others.

Type

• Point of Care Devices
• Traditional

On the basis of type, the market is segmented into point of care devices and traditional.

Stage

• Parental Stage
• Birthing Stage

On the basis of stage, the market is segmented into parental stage and birthing stage.

End User

• Hospital
• Maternity Centers
• Nursing Facilities
• Specialty Clinics
• Homecare Settings
• Others

On the basis of end user, the market is segmented into hospital, maternity centers, nursing facilities, speciality clinics, homecare settings, and others.

Distribution Channel

• Direct Tender
• Retail Sales
• Online Sales
• Others

On the basis of distribution channel, the market is segmented into direct tender, retail sales, online sales, and others.

U.S. Maternal Healthcare Devices  Market Share Analysis

The U.S. maternal healthcare devices market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to the modular construction market.

Some of the major market players operating in the market that include Medtronic, Stryker, GE HealthCare, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Hill-Rom Holdings Inc. (A Subsidiary of Baxter), FUJIFILM Corporation, Siemens Healthineers AG, Koninklijke Philips N.V.], CooperSurgical Inc., CANON MEDICAL SYSTEMS CORPORATION, Cook, Olympus Corporation, ESAOTE SPA, KARL-STORZ SE & CO. KG, Hologic, Inc., MEDGYN PRODUCTS, INC., and Healcerion Co., Ltd., among others.

SKU-70424